Personalize your feed
Only the episodes you care about
Pick your podcasts and get a free feed of their newest briefs, instead of every episode from every show.
Episodes
15,668 episodes decoded, newest first.
Mad Money w/ Jim Cramer
Cramer defends growth stocks without abandoning index funds
The episode frames portfolio construction as a balance between disciplined growth investing, diversified foundations, and clearly separated speculative risk.
Dec 30, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer turns Wall Street jargon into portfolio decisions
The episode connects investing vocabulary to practical choices about valuation, risk, taxes, diversification, and time horizon.
Dec 27, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer puts investing discipline ahead of conviction
The episode addresses how investors can limit emotional mistakes when choosing, sizing, reassessing, and exiting positions.
Dec 24, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer tests 2025 market calls against AI and real estate
The episode weighs which parts of Cramer’s 2025 outlook held up while contrasting speculative technology bets with durable logistics demand.
Dec 23, 2025 · 44 min
Dwarkesh Podcast
Post-training and reinforcement learning emerge as the new AI frontier
As traditional scaling methods encounter practical limits, the AI industry must pivot to new training paradigms to sustain rapid cognitive progress.
Dec 23, 2025 · 12 min
Mad Money w/ Jim Cramer
Cramer questions AI rally as portfolios confront concentration risk
The episode tests whether AI and data-center momentum rests on durable businesses while showing how investors can spread risk across sectors.
Dec 20, 2025 · 44 min
Mad Money w/ Jim Cramer
FedEx bets transformation and AI demand can outrun the economy
The episode connects a possible consumer-led market rally with a sharper test of which companies can convert AI spending into durable demand.
Dec 19, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer weighs buybacks, AI rivalry and tariff risks
The episode connects individual stock calls to broader forces shaping earnings, consumer competition, technology leadership and trade policy.
Dec 18, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer weighs AI fears against durable growth elsewhere
The episode tests whether an AI-led market correction signals broader risk or creates room for growth in health care, energy, and regional finance.
Dec 17, 2025 · 44 min
Mad Money w/ Jim Cramer
AI power demands collide with industrial growth and consumer credit
The episode connects household borrowing, industrial-gas demand, AI infrastructure losses, and the electricity constraints shaping data-center investment.
Dec 16, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer makes the case for plain-vanilla stocks
As speculative technology shares retreat, the episode tests whether diversified exposure and established companies can better withstand market volatility.
Dec 13, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer weighs AI infrastructure against speculative stock bets
The episode tests whether investors should favor established businesses benefiting from durable trends or accept greater risk chasing emerging opportunities.
Dec 12, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer urges fundamentals after Fed rate cut
The episode tests whether investors should follow familiar Fed-driven market narratives or prioritize companies with revenue, profits, and durable demand.
Dec 11, 2025 · 44 min
Mad Money w/ Jim Cramer
Executives defend turnarounds across AI, defense and banking
The episode tests whether ambitious corporate promises can withstand investor skepticism as AI infrastructure, defense demand, healthcare costs and interest rates reshape markets.
Dec 10, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer argues for conviction without abandoning diversification
The episode addresses how investors can stay invested through volatility while managing concentration, valuation, age, and major financial changes.
Dec 9, 2025 · 43 min
Mad Money w/ Jim Cramer
Cramer urges investors to resist crowded thinking
The episode offers a framework for deciding when to rebalance, trim winners, trust market signals, and abandon a broken investment thesis.
Dec 6, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer weighs enterprise AI against steadier bets
The episode tests whether investors should chase technology’s momentum or balance it with durable companies, pharmaceuticals, and regulated financial experiments.
Dec 5, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer revisits the warning that shook Wall Street
The anniversary special examines how Jim Cramer confronted mortgage-market danger, demanded Federal Reserve action, and endured backlash after sounding the alarm.
Dec 5, 2025 · 14 min
Mad Money w/ Jim Cramer
Cramer separates durable growth from speculative market bets
The episode argues that investors must distinguish real earnings, recurring revenue, and infrastructure demand from trades built mainly on momentum.
Dec 4, 2025 · 44 min
Mad Money w/ Jim Cramer
AWS bets on custom chips as AI demand reshapes the cloud
The episode connects market volatility and speculative weakness with the infrastructure race determining how enterprises adopt AI.
Dec 3, 2025 · 44 min
Lex Fridman Podcast
Michael Levin redefines biological intelligence as a decentralized bioelectric network
Redefining intelligence as a cellular bioelectric process opens radical new frontiers for regenerative medicine, synthetic biology, and the search for alien life.
Nov 30, 2025 · 3h 28m
Mad Money w/ Jim Cramer
Cramer makes the case for AI diversification
The episode tests whether investors can capture AI-related growth without letting hyperscalers or NVIDIA dictate an entire portfolio.
Nov 26, 2025 · 44 min
Mad Money w/ Jim Cramer
Cramer warns new share supply could strain the bull market
The episode connects AI competition, delayed economic data, retail real estate, stock-specific calls, and rising equity supply to the market’s next test.
Nov 25, 2025 · 44 min
Mad Money w/ Jim Cramer
AstraZeneca bets on U.S. expansion as markets test growth stocks
The episode connects a volatile holiday-week market with the investment case for dividends, growth, earnings, and pharmaceutical expansion.
Nov 22, 2025 · 44 min